Literature DB >> 14999149

RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells.

Mei Wu1, Zhi-Fen Wu, Chandan Kumar-Sinha, Arul Chinnaiyan, Sofia D Merajver.   

Abstract

Inflammatory breast cancer (IBC) is the most deadly form of breast cancer in humans presumably due to its ability to metastasize from its inception. In our laboratory, overexpression of RhoC GTPase was observed to be specific for IBC tumors, but not for stage-matched, non-IBC tumors. RhoC is known to contribute to an IBC-like phenotype in HPV-E6E7 immortalized breast cells. To further study the effect of RhoC overexpression on IBC metastasis, we generated stable transfectants of spontaneous immortalized mammary epithelial cells (MCF10A) overexpressing wild-type RhoC or a constitutively active RhoC mutant (G14V). Both the RhoC wild type and the G14V transfectants were highly invasive and proliferated more rapidly compared to vector-only control clones. Overexpression of RhoC led to an increase in actin stress fiber and focal adhesion contact formation. Comparative microarray analysis of these clones further revealed that RhoC overexpression upregulated 108 genes whereas seven genes were down-regulated. We have further verified by quantitative RT-PCR that genes involved in cell proliferation, invasion/adhesion, and angiogenesis were modulated by RhoC. This work suggests strong candidates for the downstream oncogenic functions of RhoC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999149     DOI: 10.1023/B:BREA.0000018426.76893.21

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  24 in total

Review 1.  Multifaceted role of Rho proteins in angiogenesis.

Authors:  Sofia D Merajver; Saad Z Usmani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-10       Impact factor: 2.673

2.  Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.

Authors:  Kenneth W Hance; William F Anderson; Susan S Devesa; Heather A Young; Paul H Levine
Journal:  J Natl Cancer Inst       Date:  2005-07-06       Impact factor: 13.506

3.  Transcriptomal profiling of the cellular transformation induced by Rho subfamily GTPases.

Authors:  I M Berenjeno; F Núñez; X R Bustelo
Journal:  Oncogene       Date:  2007-01-08       Impact factor: 9.867

4.  The current understanding of the molecular determinants of inflammatory breast cancer metastasis.

Authors:  Galina S Radunsky; Kenneth L van Golen
Journal:  Clin Exp Metastasis       Date:  2006-04-27       Impact factor: 5.150

5.  Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.

Authors:  Emmanuelle Charafe-Jauffret; Christophe Ginestier; Flora Iovino; Carole Tarpin; Mark Diebel; Benjamin Esterni; Gilles Houvenaeghel; Jean-Marc Extra; François Bertucci; Jocelyne Jacquemier; Luc Xerri; Gabriela Dontu; Giorgio Stassi; Yi Xiao; Sanford H Barsky; Daniel Birnbaum; Patrice Viens; Max S Wicha
Journal:  Clin Cancer Res       Date:  2009-12-22       Impact factor: 12.531

6.  Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.

Authors:  Darren E Casteel; Stephanie Turner; Raphaela Schwappacher; Hema Rangaswami; Jacqueline Su-Yuo; Shunhui Zhuang; Gerry R Boss; Renate B Pilz
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

7.  Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma.

Authors:  Lu Jiang; Xiqiang Liu; Antonia Kolokythas; Jinsheng Yu; Anxun Wang; Caroline E Heidbreder; Fei Shi; Xiaofeng Zhou
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

Review 8.  Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma.

Authors:  Yi Jin; Dan Chen; Robert J Cabay; Anxun Wang; David L Crowe; Xiaofeng Zhou
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

9.  The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer.

Authors:  Andrew D Hauser; Carmen Bergom; Nathan J Schuld; Xiuxu Chen; Ellen L Lorimer; Jian Huang; Alexander C Mackinnon; Carol L Williams
Journal:  Mol Cancer Res       Date:  2013-11-06       Impact factor: 5.852

10.  Microarray and pathway analysis reveals decreased CDC25A and increased CDC42 associated with slow growth of BCL2 overexpressing immortalized breast cell line.

Authors:  Jacquelyn M Long; Charles W Bell; W Samuel Fagg; Mary E Kushman; Kevin G Becker; James A McCubrey; Mary A Farwell
Journal:  Cell Cycle       Date:  2008-10-08       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.